Já nem no Tamiflu se pode confiar...
Excertos de um artigo publicado hoje no Financial Times:
Roche the Swiss pharmaceutical group, on Thursday moved to reassure investors after US regulators said they would on Friday examine reports of up to 12 deaths and 75 cases of children who suffered health problems after using Tamiflu, the company's anti-flu drug.
The news presents a dilemma for governments drawing up contingency plans to prepare for a potentially lethal bird flu-derived pandemic, for which Tamiflu is widely viewed as the most practicable short-term drug for treatment and prophylactic use.
It presents a fresh challenge to Roche, which has seen demand for Tamiflu rise sharply in recent months towards projected sales of $1bn (€860m) this year.
President George W. Bush, recently earmarked $1bn for buying pandemic stockpiles, and about 50 governments have placed similar orders.
Sem comentários:
Enviar um comentário